The chemotherapeutic drug doxorubicin does not exacerbate p16Ink4a-positive senescent cell accumulation and cardiometabolic disease development in young adult female LDLR-deficient mice
Autor: | Postmus, Andrea C., Kruit, Janine K., Eilers, Roos E., Havinga, Rick, Koster, Mirjam H., Johmura, Yoshikazu, Nakanishi, Makoto, van de Sluis, Bart, Jonker, Johan W. |
---|---|
Zdroj: | In Toxicology and Applied Pharmacology 1 June 2023 468 |
Databáze: | ScienceDirect |
Externí odkaz: |